XML 114 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 14 - Employee Benefits - Activities Under All Plans (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Weighted average exercise price (in dollars per share) $ 11.21    
Granted (in shares) 0 0  
Shares available for grant (in shares) 345,907    
Restricted Stock [Member]      
Unvested restricted shares outstanding (in shares) 22,841    
Share-based Payment Arrangement, Option [Member]      
Options outstanding (in shares) 34,229    
The 2009 Plan [Member]      
Shares available for grant (in shares) 0 0  
Weighted average exercise price (in dollars per share) $ 11.21 $ 11.21 $ 11.21
Vested (in shares)   0  
Shares available for grant (in shares) 0 0  
The 2009 Plan [Member] | Restricted Stock [Member]      
Unvested restricted shares outstanding (in shares) 0 3,102  
Vested (in shares)   (3,102)  
Unvested restricted shares outstanding (in shares) 0 0  
The 2009 Plan [Member] | Share-based Payment Arrangement, Option [Member]      
Options outstanding (in shares) 34,229 34,229  
Vested (in shares)   0  
Options outstanding (in shares) 34,229 34,229  
The 2017 Plan [Member]      
Shares available for grant (in shares) 365,742 388,971  
Vested (in shares) 0 0  
Shares available for grant (in shares) 345,907 365,742  
Options outstanding (in shares) 0    
The 2017 Plan [Member] | Granted January 28, 2020 [Member]      
Granted (in shares)   (10,650)  
Granted, vesting period (Year)   3 years  
The 2017 Plan [Member] | Granted April 23, 2020 [Member]      
Granted (in shares)   (9,000)  
Granted, vesting period (Year)   2 years  
The 2017 Plan [Member] | Granted April 28, 2020 [Member]      
Granted (in shares)   (3,579)  
Granted, vesting period (Year)   1 year  
The 2017 Plan [Member] | Granted January 26, 2021 [Member]      
Granted (in shares) (16,685)    
Granted, vesting period (Year) 3 years    
The 2017 Plan [Member] | Granted April 27, 2021 [Member]      
Granted (in shares) (3,150)    
Granted, vesting period (Year) 1 year    
The 2017 Plan [Member] | Restricted Stock [Member]      
Unvested restricted shares outstanding (in shares) 21,484 14,787  
Vested (in shares) (11,866) (8,789)  
Unvested restricted shares outstanding (in shares) 22,841 21,484  
The 2017 Plan [Member] | Restricted Stock [Member] | Granted January 28, 2020 [Member]      
Granted (in shares)   7,100  
The 2017 Plan [Member] | Restricted Stock [Member] | Granted April 23, 2020 [Member]      
Granted (in shares)   6,000  
The 2017 Plan [Member] | Restricted Stock [Member] | Granted April 28, 2020 [Member]      
Granted (in shares)   2,386  
The 2017 Plan [Member] | Restricted Stock [Member] | Granted January 26, 2021 [Member]      
Granted (in shares) 11,123    
The 2017 Plan [Member] | Restricted Stock [Member] | Granted April 27, 2021 [Member]      
Granted (in shares) 2,100    
The 2017 Plan [Member] | Share-based Payment Arrangement, Option [Member]      
Options outstanding (in shares) 0 0  
Vested (in shares) 0 0  
Options outstanding (in shares) 0 0  
The 2017 Plan [Member] | Share-based Payment Arrangement, Option [Member] | Granted January 28, 2020 [Member]      
Granted (in shares)   0  
The 2017 Plan [Member] | Share-based Payment Arrangement, Option [Member] | Granted April 23, 2020 [Member]      
Granted (in shares)   0  
The 2017 Plan [Member] | Share-based Payment Arrangement, Option [Member] | Granted April 28, 2020 [Member]      
Granted (in shares)   0  
The 2017 Plan [Member] | Share-based Payment Arrangement, Option [Member] | Granted January 26, 2021 [Member]      
Granted (in shares) 0    
The 2017 Plan [Member] | Share-based Payment Arrangement, Option [Member] | Granted April 27, 2021 [Member]      
Granted (in shares) 0